Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Medicine, Adverse effect, Pharmacovigilance, Infliximab, Etanercept, and Adalimumab.
Safety issues of tofacitinib in rheumatoid arthritis patients: real-world pharmacovigilance
The adverse reactions of bevacizumab in combination with the FOLFOX chemotherapy regimen in metastatic colorectal cancer
Safety of TNF-α inhibitors: A real-world study based on the US FDA Adverse Event Reporting System Database
Exploring the evolutionary mechanism of hepatitis B and gastric cancer based on Mendelian randomization combined with bioinformatics analysis
Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System
Tumor Necrosis Factor α-Induced Protein 1 as a Novel Tumor Suppressor Through Selectively Downregulation of CSNK2B Blocks Nuclear Factor-κB Activation in Hepatocellular Carcinoma